J. Goldman & Co LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$32,226
-16.3%
29,8390.0%0.00%0.0%
Q2 2023$38,492
-2.3%
29,8390.0%0.00%
-50.0%
Q1 2023$39,387
-12.0%
29,8390.0%0.00%0.0%
Q4 2022$44,759
+27.9%
29,8390.0%0.00%0.0%
Q3 2022$35,000
-81.2%
29,839
-81.9%
0.00%
-77.8%
Q2 2022$186,000
-88.3%
164,839
-68.9%
0.01%
-87.5%
Q1 2022$1,584,000
+211.8%
529,905
+176.2%
0.07%
+157.1%
Q4 2021$508,000
+99.2%
191,839
+172.7%
0.03%
+115.4%
Q3 2021$255,000
-81.5%
70,339
-77.9%
0.01%
-75.9%
Q2 2021$1,382,000
+737.6%
318,456
+560.3%
0.05%
+980.0%
Q1 2021$165,000
-83.9%
48,229
-83.5%
0.01%
-90.4%
Q4 2020$1,026,000
-49.3%
293,039
-65.2%
0.05%
-62.0%
Q3 2020$2,022,000
+7.6%
842,486
-18.0%
0.14%
+18.1%
Q2 2020$1,879,000
+311.2%
1,027,046
+250.5%
0.12%
+110.9%
Q1 2020$457,000
-84.5%
292,999
-64.8%
0.06%
-56.0%
Q1 2018$2,947,000
-24.6%
832,500
-17.3%
0.12%
-39.0%
Q4 2017$3,907,000
+64.5%
1,006,900
+7.7%
0.20%
+70.8%
Q3 2017$2,375,000
+45.4%
935,000
+56.4%
0.12%
+36.4%
Q2 2017$1,633,000
-0.1%
598,000
+21.1%
0.09%
+8.6%
Q1 2017$1,635,000
-12.0%
494,000
-36.7%
0.08%
-34.1%
Q4 2016$1,859,000
-32.6%
781,000
+3.9%
0.12%
-21.2%
Q3 2016$2,759,000
+69.7%
751,629
+3.1%
0.16%
+83.5%
Q2 2016$1,626,000
+88.9%
729,200
+76.2%
0.08%
+60.4%
Q1 2016$861,000413,7890.05%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders